Episode 36 – Building Businesses: Roadmaps, risks and rates of change with Andy Shafer

Jun 27, 2024

In this episode, I had the opportunity to catch up with Andy Shafer, who’s been a leader in building businesses in the 21st century biobased economy. A Dow Chemical alumnus, he started his ‘bio-journey’ with NatureWorks, a Joint Venture between Dow Chemical and Cargill, where he had a leadership role in bringing PLA to market. He then moved to Elevance Renewable Sciences for 9 years, establishing their market facing partnerships including sales and marketing, corporate brand and communications. He then spent 7 years in private consulting, including the authoring of a book on strategy and ROADMAP development, before joining Gevo in late 2023 as their Chief Marketing, Customer and Brand Officer.

In our discussions, Andy reflects on his journey into the biobased economy and early involvement in the market development of PLA. It was striking that a reframing of the questions and potential benefits lead to a dramatic shift in strategy, leading to a focus of performance in use and less on the fact that it was a ‘bio’ product. His shares some observations on bringing a new joint venture together, with a team of different industrial backgrounds (and allegiances), and the process of bringing that team together around the JV’s mission. He also reflects on the resources and reputation that comes with a new JV entity in contrast to its (larger) parents.

One of the challenges we discuss is developing ‘proof of concept’ to customers with constrained resources and the need to look toward creative collaborations. Andy sees segmentation as critical to tech transfer as this involves identifying who is going to help you be successful. He also notes that this isn’t necessarily the obvious, discussing fast followers rather than incumbents as they may not have the reputational risk associated with trying new approaches. We touch on the role of laggards or, as per Episode 7 with Paul Bryan, the role of the desperate customer.

Andy also reflects on the rate of change and introduces the notion of ‘stopwatches vs calendars’. We touched on the importance of timing in Episodes 10 and 13 and how these impact tech transfer outcomes. Here, Andy notes that clients can move at different rates to new ventures. He also notes that capital intensity and downstream supply chain partners, all need time to adjust and adopt new approaches. We touch on how ownership and the introduction of new investors through fundraising rounds can also be subject to asynchronous timing outcomes. The need for synchronicity between investors throughout the life of a venture is critical to sustainable success. Andy discusses how investor misalignment can drive different operational behaviours and outcomes.

We close by discussing his new role at Gevo, and team members Pat Gruber, Chris Ryan and Bill Baum, acting as a gravitational force to bring Andy back into corporate life from his consulting activities. Andy sees Gevo as an opportunity to “help transform another industry on a mission that matters”. In taking on the challenge of bringing Sustainable Aviation Fuel (SAF) to market, we again reflect on rates of change and risk.

Transcript

CB: Hello, everyone. Welcome to Tech Transfer Talk. My name is Cameron Begley from Spiegare, a tech transfer advisory firm. And joining me today from Chicago is a long-standing colleague of mine, Andy Shafer. Andy, good afternoon to you. How are you?

AS: Doing great, Cameron. Glad to be here today, thanks.

CB: Absolutely delighted to spend some time with you today, Andy. Perhaps a little bit of your background story at Dow before you made this leap into the bold and brave new world of biobased materials and biobased products.

AS: Well, I’m sure you’ve heard me tell the story, but I’m a business guy who got a chemical engineering background. And as my dad says, I graduated summa cum barely. Because I wanted to be a business guy, not an engineer. But I wanted to be able to…I wanted to be able to talk the language of the chemical industry, and you had to go get the math and science necessary to be able to understand the problems and talk the language. And so, I went and did that summa cum barely.

CB: Summa cum barely, right. And from there, were you straight into Dow, Andy?

AS: I went straight into Dow. I was in sales. I was in market research. I was in business leadership. I helped as we as we move from a geographically defined US business to a first of North American business and then a global business, and I wrote the global strategy for one of our businesses, and then handed it off to another team to, to go and execute lead. And, and that led to my opportunity to go and and explore the NatureWorks adventure.

CB: Fantastic. So, when did you move into NatureWorks? What year was that? Roughly 05, 06?

AS: So, we started, the Cargill and Dow interface that became NatureWorks, started as an exploratory collaboration when I was in the polystyrene business, and that was in 1997.

CB: Wow. Okay.

AS: The, the, the business vice president came to me and looked at me and said, ‘It’s your business. You better figure out if it’s a threat or an opportunity’. And that’s where we started, was assessing the fit for PLA, within the Dow world, as a biobased plastic, a biodegradable based plastic is how it was positioned by Cargill at that point. And that was in 1997. And I became first a seconded employee and then a joint venture employee over time.

CB: Yeah. So, when you think back to those reviews. Greater opportunity. Set aside how it might look now, what was the thinking then?

AS: So, the first, Cargill‘s approach to the business was as a biodegradable, compostable plastic. and, And that was the value proposition. And one of the things I’m sure we’re going to talk about today is what is the value proposition for a new technology? And I originally told the two VP’s that were doing the decision making for Dow. Now, if this isn’t a market opportunity that’s big enough for either Dow or Cargill in a time frame that we care about, much less a business big enough to split. And then I went to bed that night and thought, ‘No, that’s the wrong answer’. And I got up and fortunately I knew one of the VP’s well enough. I called her at home at like midnight and said, ‘I gave you the wrong answer’. And she said, ‘Well, you better call Jim’ who was the other VP, and ‘He’s on a plane to Singapore, so you better call Singapore and tell him you gave him the wrong answer and see what he has to say’. And I woke up at 3 ‘clock in the morning when the phone rang and Jim was in Singapore calling me, saying, ‘What do you need to talk about now?’ I thought, sure, I didn’t have a job at that point. And he came back and he said, ‘Okay, what’s it going to take you to give me the right answer?’ And I told him, and he said, ‘Okay, you’ve got that. Don’t give me the wrong answer twice’. And that’s what led to the, that’s what led to the joint venture.

CB: Wow. Almost a bit of a sliding doors moment there, Andy, where you sort of instinctively went one way, stopped, reflected and then thought, not better of it, just differently of it.

AS: It was… We’d spent all of our time assessing the opportunity as a biodegradable and compostable plastic, and the assessment said that market wasn’t going to grow fast enough. The infrastructure for composting wasn’t going to grow fast enough. And, and therefore as a, as an investment opportunity, it didn’t make sense. But when I took a step back, that didn’t feel good because what the polymer did was different. And when we, when I looked at it from that point of view, it was like, ‘Wait a minute, we asked the wrong questions’. And so it was that, that I realised we need to go ask the questions differently. And when we did, the customer said, ‘It does what?’ And before they had said, ‘We’re not interested in biobased plastic or biodegradable plastic or compostable plastics’. But when I said it did this and that, they were like, ‘It does what? That’s interesting, let’s talk’.

CB: So, it was a reframing. It was a reframing from what you might call the bio characteristics to the material property characteristics. You started talking about thee benefit in use, not the perceived benefit post use.

AS: Exactly.

CB: Right, and that may well be a theme that recurs from time-to-time here as we talk about the journey of biobased that, I think we’ve all been guilty. I’m going to go out on a bit of a limb here, Andy, but I think we’ve all been guilty of being in love with the bio bit, and perhaps not as focused on the material properties and the customer benefit bit. We’ve just been a little bit skewed in our thinking from time-to-time. I suspect we’ve all been guilty of it. And I guess it’s a credit to you, Andy, and maybe, and perhaps more broadly, the industrial people that think in terms of customer benefit as opposed to the more evangelical members of our community who just think about the bio bit.

AS: And, I would say it’s not just the material properties, it is that customer benefit that…What’s the customer problem. Customers didn’t have a problem with composting. That wasn’t what they wanted to do. They had a problem with the materials not performing in the way that they wanted. And that’s what unlocked the opportunity for PLA.

CB: Yeah. Absolutely. Fantastic. So now, having stumbled upon that question and answering that question, you find yourself now inside NatureWorks. How was that joint venture environment? So, you’re now new polymer or notionally new polymer, and you’re now taking that to market in a joint venture. So, the dynamics internally are different. The dynamics externally are different. What are your recollections of that period about that from building a market and dealing internally and externally?

AS: So, internally there were kind of three things that I would say were really interesting. You went from having one clear parent, if I can use that analogy. Right. I’m living with this parent. I know how this parent behaves. I know what this parent wants. I can do that and make that parent happy all day long. And then suddenly you had two. And they were they were different. And the siblings that were in the analogy, right, came from one of the two parents. And we would have the employees of NatureWorks…We would have team meetings where we’d have people from Cargill and people from Dow. And both sides would be describing things that they thought, things that they had done, ways that they’d behaved. And they’d say, ‘We. We did this, we did this, we do this, we do this’. And we had one meeting where the CEO of the company said, ‘The next person who says we and doesn’t mean us, the people in this room, but means we, the people you came from, the company you came from, is going to leave’.

CB: Wow.

AS: ‘Your option to not leave the room is to put a dollar on the table’. And one guy got up and he put $100 bill on the table. He said, ‘Just tell me when I need to add more’. And we gave $230 to charity at the end of that meeting because people kept saying ‘we’, meaning where they had come from, not where they work now. So it was, who are you as a joint venture, right? And I take that when as we grew the company and later on in some of the adventures that I was on, that we’ll probably talk about later, I used to talk about being Ellis Island, that we all come to this place with, Sorry, it’s a US…

CB: No. I understand the immigration entry point for those that are not familiar with it. Immigration entry point for the United States. Yeah.

AS: And people came from all over the world, and they came to that point, and they brought their luggage, and they brought their language, and they brought their experiences, and they brought their history, but none of them had the same. It was all different. It came from all different places. And that was this big melting pot of all of that, where suddenly you had to figure out how to make it work with all those different backgrounds. That’s what it was in some of these new companies that we, that in the NatureWorks adventure and in some of the companies I’ve been involved in later, figuring out who’s ‘we’ and getting that language to be consistent and getting that culture to be consistent was a big part of the challenge.

CB: Fascinating, fascinating. Externally, what was sort of the one or two of the key things externally that you noticed, now you’re bringing this new material, and introducing new materials to industrial markets is not a trivial challenge.

AS: And when you come from a company like Dow Chemical or you come from a company like Cargill, you come from a company with a lot of credibility and gravitas. And when you’re suddenly this new entity, it’s ‘So what? And who cares?’ You don’t have that same credibility. You don’t have that same gravitas. You don’t have the same resources behind you to prove a point or to make something valid. And so, that’s really hard to recognise that shift and, and overcome that, maybe not recognise it but overcome that, and to be able to get the same level of marketplace appreciation that you had from where you worked before.

CB: Yeah, that’s a really interesting comment there, Andy. And certainly, you’ve run your own advisory business. And, you know, I clearly run mine. And all of a sudden, yet the brand’s gone. It’s now almost purely relationship based. There’s no brand to support the relationship.

AS: There’s no big company behind it. The brand is you.

CB: The brand is you.

AS: And it’s your personal, your personal brand that you built from your reputation over the years. And in this case, it’s a company that doesn’t even have that behind them. Right. There’s a new entity, doesn’t have all that doesn’t even have you behind it. It’s got to start from scratch to build all that. So then how do you get attention and how do you get credibility and how do those two things work hand-in-hand. And you see a lot of new companies hype stuff and then it doesn’t happen. And then their credibility’s shot. And you can’t do that. You gotta have the traction there. And then having the resources to go prove something or to go do the research or to go invest in something and make it happen. New companies often don’t have that level of capability. And, and you know, where Dow Chemical you could go get some analytical done overnight, very quickly, very efficiently. You may not be able to do that as a new entity. So, there’s a lot of challenges in how you manage that.

CB: You’ve raised a very interesting tech transfer point there, Andy, it’s that issue of introducing a new product, a new solution, whatever it might be, and trying to build that credibility, those proofs of concept, proof that it works. Yet without the resources, without the ability to just throw everything against the wall in order to make it happen. NatureWorks, backed by two pretty significant corporates, yet you’re reflecting on that experience. How did you as NatureWorks and, in your role, how did you overcome that challenge of limited resource and trying to prove out this new product being PLA, proving to people that it deserved a place amongst the client base to solve problems.

AS: So, you make a good point. We were backed by two really large, reputable and interested and committed, parent companies. But we also had to do stuff on our own to justify to them what we needed to do. And so, you get really creative about how you collaborate. You get really creative about who you collaborate with. And I think one of the things that’s critical to tech transfer is segmentation. Finding out, you know, segmenting the market and finding the people who are really going to help you be successful. Whether it’s they’re having the same problems that you’re trying to address. And there’s a common problem there or, you know, whatever the common thing is in the segment that makes that segment fit with you, is so easily overlooked. And you tend to go to the obvious and it’s not the obvious where you get that stuff to happen. It takes deeper sophisticated segmentation.

CB: That’s a great insight, Andy. I’ve from time-to-time reflected on you probably are looking for the fast hungry follower to be those partners rather than the big steady incumbents. Yet I think there’s a natural tendency to be drawn towards the incumbents because they’ve got cash and they’ve got market position, but they don’t necessarily have the hunger or the problem you’re trying to solve.

AS: Well, and often those are folks with a brand or a reputation that they don’t want to risk.

CB: Mhm. That’s a good point. Yeah.

AS: Their willingness to risk their brand on something new or something different or something that might have some not fully developed or ready for prime-time attributes, is a big risk for them. They’re not going to risk to that brand. I used to talk about whose business is in trouble, whose business has to do something different. Looking for someone who’s at risk in the marketplace and has to find a new solution can be a very willing and committed partner.

CB: Yeah, that’s a great question to ask, actually. Great question to ask. Who’s in trouble? Yeah, we had Paul Bryan on the podcast some time back and he spoke about the role of the desperate customer. So very, very similar sentiments there between you and Paul, I think. But perhaps yours is more elegantly expressed, I think, Andy.

AS: But well, at times I was, I would challenge my team and I’d say, ‘Look for the losers. Who’s losing market share? Who’s losing revenues? Who’s business is struggling?’ Because those are the folks that need to do something different. And if the conditions are right. And so, you always got to be looking at the conditions. The conditions are right. Those people can be phenomenal partners. Because one of the other external things that I think is really, a great analogy, is when you’re in one of those emerging technology transfer situations, you’re measuring progress with a stopwatch. You got to make stuff happen fast. And big companies tend to use calendars to measure progress.

CB: We’ve spoken about time and timing before, and that’s nice. Calendars versus stopwatches.

AS: It’s a huge difference in, so often it’s a source of tension between companies that are trying to get new technology adopted and companies that might be interested in adopting new technologies. It’s a huge tension.

CB: Yeah. So, with that, with the calendar versus stopwatch concept in mind here, Andy, just to take a moment to wrap up the NatureWorks story in a way. So, here we are in 2024, as we record this and we look back at PLA, the amount of market uptake it’s had and how it’s gone. All of the hope that we brought into the market in that time, you could really build a quick case that’d say that the market uptake is just not been there. What are your thoughts on perhaps why, and how we might have looked at that differently?

AS: Yeah, I think the piece that we didn’t factor in was, was how challenging it is and how long it takes this industry to change. You think about if you think about PLA. PLA is still the biggest new polymer that’s been introduced in the past 50 years. So, it now has multiple producers. It has multiple world scale plants. And yet it’s still a fraction of market share of the polymers industry. But it’s also, it was on the forefront of what is today green polyethylene. And green polyethylene has grown tremendously. So, it was one of the first bio or green polymers introduced into the marketplace. And I think so, if we think about the capital intensity of this industry and how long it takes to get that capital established and built in and in place, and then if you think about the applications development and how complex that is, you have to go downstream. And I think we often underestimate how long it’s going to take to go downstream and prove in all the steps in the supply chain this is going to work. It’s going to meet the needs. It’s going to be a better solution. It’s going to be economically viable. All those elements all the way through the supply chain, just takes an enormous amount of time. And I don’t believe we appreciated that in the late 90s.

CB: Yeah, that notion of the value chain is a really interesting one. I agree with you that this gets underestimated. When we’re dealing with early stage, we talk about value pools and all of the different actors have to get a benefit one way or another. Whether it’s a financial benefit or an environmental benefit, social benefit, policy, whatever it is, everyone’s got to get a win. And anyone who doesn’t get a win, all of a sudden, the whole thing can topple over or get held up or get delayed. And thinking all of that through is incredibly complicated, I think for just about any piece of tech transfer, let alone something like a new material such as PLA.

AS: And you also have to think of the dynamics around that. That’s very true. And one link in the chain that doesn’t get a benefit and everything stops. And another challenge, we were dealing with a yogurt cup manufacturer when I was working with PLA, and we couldn’t make progress with them on a steady basis. And I went to see them, and I sat down with the product manager, and I was talking with him about why are we struggling here? And he said, ‘Andy, you guys come in and you talk about making a change, but it’s going to take you a year to get that into the product because of what you need to do in the polymer and how long it takes to do’, and he goes, ‘In a year, we’re going to have two people in my job after me. So, I’m going to rotate through, I’m going to be off on the next job. The next guy’s coming in, he’s going to be out for the next job. The third guy’s coming in. You’re going to be talking to him about what you told me you were going to do, you know, 9 to 12 months ago. And so, you’re going to start all over again with him, and he’s going to be gone twice before you get a chance to show the benefit to him. So how much time are we going to pay attention to what you’re bringing in here to solve our problems? Because I’m going to get promoted twice before you’ll even have a chance to have an impact. I’m really not getting a benefit from you being here’. So, it was eye opening in terms of how fast some of the other industries were changing compared to how fast we were able to deliver.

CB: That’s really fascinating on two levels there, I think, Andy. One is that calendar versus stopwatch concept, because these people were running on stopwatches, you were running on calendars. The other piece is the people piece, right? They fall over two in every three times because of people; not because of the technology or the regulation.

AS: You not only have to have everything right for the business to be successful, but the individuals that are managing that business or responsible for that business also have to see it as a personal success. I totally agree with you.

CB: The people involved matter. They have to have their wins along the way. Absolutely.

AS: Absolutely.

CB: Yeah. So, with the PLA adventure reaching its end, off to Elevance, if memory serves into fats and oils and waxes and all sorts of really cool stuff, which is kind of where we really got talking in terms of potential collaboration, if memory serves.

AS: So, I went, I took a brief stint back to Cargill…

CB: Oh, I didn’t realise that.

AS: I’d left NatureWorks and I went back to Cargill because that’s where Elevance started. It was Cargill that had the relationship with the technology company, Materia, under a DOE grant. So, I went from big company to joint venture back into big company. So, it was the shock of big company, little company, and what did I do? And then it was the shock from little company to big company. And it’s like, ‘Oh my God, what did I do again’. So, they all have their, they all have their tradeoffs. And then I realised I’d gone from being able to sign a $100,000 invoice to being able to sign $1 million invoice, you know, just by changing roles. So, the accountability piece changes. But going from, then we spun elements out of Cargill, and we went from a privately held, publicly traded company to a private equity venture capital organisation. And so that was a huge shift in what took place. And you know, you talk about culture in, in environment. Who you get your capital from matters.

CB: Yeah. Okay.

AS: Where the investment is coming from for your technology development or technology transfer, really matters. Their motivation, their patience, their understanding of that technology and what it will take to successfully develop it, is all critical to what you’re going to look like as you’re successful.

CB: That’s a really interesting comment around the type of money you get and the patience and the rest of it. With that said, did you feel that align strongly for Elevance? Were you off to a good start with the capital aligned to the time horizons of Elevance and the path to market?

AS: It was very well aligned early and Elevance went through multiple, multiple investment rounds, we went through five private equity investment rounds. And we wrote the S-1 to go public before pulling in and doing the E round. And as that investor base diversified, it became less aligned with what we were trying to do.

CB: Right. And did that, and was that problematic, do you feel, or was that just the natural evolution of a of a startup maturing as it got closer to, and into, market?

AS: It became problematic in that the patience behind the business and the understanding of the technology development, got diluted. And they rushed to capitalise on the exit pathway, at the expense of the business development, for what it would, what it was going to take in terms of timing to build the marketplace, to get some of that applications development work completed.

CB: So, what emerged was an asynchronicity between the timing of the business and the timing of the investors.

AS: Correct.

CB: Right. Okay. Okay. So, from your perspective there, Andy, how was that playing out, perhaps more so in the business development side, it sounds like that got constrained or affected by that asynchronicity.

CB: Yeah, the pressure to get stuff done faster became a perception of ‘the customers aren’t committed’. And so there became a pressure to push more and more and more onto the customers and make them commit to stuff that what they weren’t going to be able to commit to from the timetable that they had. And that led to problems with customers.

CB: So, the asynchronicity put a pressure on to get customer commitments come forward in time, rather than allowing those to mature at perhaps the pace they needed to.

AS: Right.

CB: Yeah. Okay. And that in turn is going to build a little bit of customer resistance and relationship challenges, I’m sort of guessing flows on from that.

AS: Yep. Yeah. And that led to that led to challenges.

CB: Yeah okay. Okay. No, really interesting. Internally, how was the team dealing with these things? Because I guess when you’ve got that closer alignment internally, it’s a really good, aligned group. Does the shift in the types of skills you need start to emerge as the, not only is the business matures generally, but in this particular circumstance, did you find you needed to do more BD, or you needed more technical? What was the shift internally around the skill set?

AS: It shifted the…we tried to shift more of the work out of the customers, because if they’re committed, they’ll do this, right. It was that we tried to push it to customers. And that led to them saying, ‘Well, then we’re less interested in doing this, right. You guys need to be collaborating with us to do this’. And it led to a tension between customer, you know, customer partners that were doing development work with us. And ultimately then, it led to some internal tensions across the team, as we tried to get stuff done for the organisation.

CB: I’m very sensitive that people involved in this, in history, that we won’t go much deeper into. But the thing that strikes me there is that from a startup and tech transfer perspective, you’re externalising product development work to your client base and sort of moving that cost, both direct and indirect. You’re moving that out to the clients. And I just instinctively, depending on how well developed you are as a business, that could be problematic not just in terms of relationship, but your, you know, the way you manage your intellectual property and your knowhow starts to get a little bit muddled as well because that those learnings that you have by internalising it can then be subsequently monetised through a whole lot of different ways. Whereas if that learning and knowhow is with, you know, customer X, then it’s a little bit harder to draw that in. And I think perhaps a bit impolitic to say, ‘Well, thanks for telling me that. I’m now going to sell it to customers Y, Z, D, F and G’. It’s…Yeah.

AS: So, it manifests itself in a couple of ways that I would agree. That there’s, first of all, the receptivity of the customer to do that work versus accept work you have and build on it with their own work. So, there’s that interface between you and the customer, but it also starts to shift the value equation. If the customer is doing more of that work, then, you know, what their perception of the value of the relationship is, shifts. And it shifts as you mentioned, the IP. Where value is being captured in the in the relationship can also move. And all of that was leaking out to the customers. So, they were starting to get all the benefits of what’s there. And what they needed from you was just a commodity, right. And so, it shifts the value proposition considerably, as you start to think about what’s the balance between what we’re doing and what the customer is doing and, and how fast do we think we’re going. And what’s really happening here.

Right. You’re kind of self commoditising, which is probably the antithesis of what you set out to do. And yeah, really. Okay. Some really interesting implications is all those things, all that, all that equilibrium gets shifted. Some really interesting implications, not only inside the boardroom and amongst the financiers, but also amongst the customer base. So yeah, some really interesting lessons. I suspect a lot of those lessons found their way into your consulting business, which carried you forward for a few years from that point before we get into Gevo.

AS: Yes, there’s, there was a lot of, you know, conditions create opportunities, right. We all talk about we talk about markets, and we talk about technologies. But conditions, both conditions in the marketplace and conditions at the partners. You talked about look who’s struggling. We talked about look who’s trying to protect a brand or conditions in your company. What do you need to do to be successful? All those conditions matter a lot more than what we give them credit for. When we do do assessments of technology, we look at market, we looked at technology. We don’t put that same level of microscope on conditions, and they’re probably the biggest factor.

CB: Yeah, you might be giving away a bit of your own IP here, Andy, but I suspect that issue of conditionality or conditions, frequently when we deal with, particularly with the earlier stage technologies, we actually try and force people to write down the conditions for success. What does success look like, and what are the assumptions that sit behind the conditions that we write down? So, while we might be able to research some things, you know, markets and customer interviews and the like, sometimes we have to make assumptions, particularly when we’re early stage with some of these technologies. So, it’s very interesting that you dig into the conditions.

AS: Well, I’ll give you a couple examples. I use the term roadmap. I did a lot of strategy work, and I needed a simple framework for strategy. So, I like talking about strategy using the word roadmap. So, results: where are you trying to go? What are you trying to achieve? What does success look like? Opportunity: How are you going to get to success? What are you going to do that allows you to get to that destination? Advantage: Why are customers going to help you win that opportunity? And why do you keep it from your competitors? And then, design: What do you have to do to enable advantage, to get to the opportunity, and get to the result you want? And part of the opportunity is looking at ‘What are the conditions to be successful?’ And if we think about the digital cameras that we all carry around on our cell phones today, right. The digital photograph was invented way before the cameras and the computers all had the capability to do it. Polaroid and Eastman Chemical Company invented the digital photograph. They didn’t have the computing power, and they didn’t have the ability to print those digitals or to display them on big screens. So, the conditions weren’t right for those photographs to be compelling as digital photographs. And it wasn’t until those things came to be. So, what else do you need to enable your solution is one that gets overlooked, right?

CB: Yeah. That issue of ‘what else is needed to enable’ is a very broad and interesting conversation with tech transfer. It’s really easy to think that you’ve got THE solution, I think. And I think to some extent, Andy, we see a little bit, if not a lot of this in Agtech at the moment, where everyone’s coming with their solution as THE solution, where the truth of it may well lie in the fact that it’s a combination of a number of these ventures, putting together a whole package of solutions that will actually move the needle on some of these market problems. And there are lots of reasons why people think they’ve got the one. Part of it is human. Part of it is, of course, the investors wanting to be THE one. So, they, you know, their returns on investment and so on and so forth. But it’s really, it’s an interesting question of what else is needed to be true, what else needs to exist in order to enable your particular solution? The Kodak Eastman one’s are really interesting. There are lots of different layers to that story, but you do make a legitimate point about, well, there were technology conditionalities that didn’t hold when they made the early patents and inventions.

AS: Yeah, you had no way to display the photograph other than the little tiny, you know, one that came out of the camera, which wasn’t that compelling, right?

CB: No, not at all. Not at all. And what a different world we find ourselves in now. I thought, Andy, that, you know, you were probably set for life in the consulting world and going to enjoy the flexibility that comes with that. The beauty of choosing who you work with, both from a client perspective and also from the teams you build around problems. And I’m confessing they’re two of the things I really like about it. And then, a little bit out of the blue, I have to say, for me, you took a role at Gevo, which is terrific for Gevo and of course, for you. And I got the sense that came a bit out of the blue for you as well.

AS: It did. I thought I was set too. I thought I was good. The consulting business was going well, I was working with some really fun clients. I was making all the income I wanted to make and needed to make, and I had plenty of time to go play and kayak and hike and do all the things that I enjoy doing when I’m when I’m not behind a computer screen or in front of a customer. And, when the phone call came in and the chairman said, ‘Hey, we have an opportunity for you’. I was like, ‘Great, I’d love to consult with Gevo’. And he said, ‘No, no, we’re going to hire you’. And I said, ‘Well, that’s really nice because I’m not looking for a job’. And, two weeks later, here I was, an employee. So that surprised me as much as it did everybody else.

CB: Of all the possibilities that get presented to, I’m sure it wasn’t the only group that approached you in that time, Andy, I’m almost certain of it. Why, though, at this moment in time with where we’re at in the biobased economy and all the things that are happening, why Gevo now?

AS: So, there were there were three things that were critical to it. One was it was a team I knew and liked. So, CEO of the company is Pat Gruber, who was the Chief Technology Officer of NatureWorks. The President of the company was Chris Ryan. And Chris was one of the people at NatureWorks that was at the team there. And Bill Baum, who’s the Chairman, I’ve known in the renewables industry for a couple of decades. And I knew that team. I liked them, I knew I could work with them. And equally, importantly, it’s a team that gets stuff done.

CB: Yeah. Okay.

AS: And Paul Blum joined that team as the Chief Carbon Officer. And I know Paul from being in industry, and he’s another guy who’s got great experiences in the business and another guy who gets stuff done. So, I was joining a team I like, that gets stuff done.

CB: Very, very good criteria to start with. Yeah.

AS: And then, it’s an opportunity to help transform another industry. It’s a mission that matters. So yeah, I really feel that PLA opened up the world for biobased plastics. And that was part of what I had to unlock from finding a way to make a product that cost more, work in an ecosystem and open that industry up, and aviation and decarbonising the aviation industry with SAF, and some of the things Gevo can do with decarbonising chemistries, was also a mission that was interesting and the chance to do it a second time. You know, few people get a chance to do it once in their lifetime. I get a chance to do it with industry leaders a second time.

CB: Nice.

AS: And that was pretty, that was pretty enticing. And then the third thing that got me to do, it was, as we talked with, a little while ago, structuring the role so I could go do what I really enjoy doing and what I have the experience and skill sets to leverage around: how to how to establish customers that want to develop a new value proposition; how to build an ecosystem; how to how to define or redefine that value proposition; how to identify and segment a market to be able to make all that happen. Those are things that I find creatively stimulating and interesting. And we structured the job to do that. And so, when I got all done and, you know, they of course made the compensation package interesting. So, by the time I got all done, I looked at my wife and I said, ‘So the only reason I could say no to this is if I just don’t want to work. Because it’s people I like; it’s a mission that matters; it’s a job that’s structured for me and they’re paying me fairly. How can I argue?’

CB: And so, you didn’t argue. You signed on the dotted line.

AS: Here I am.

CB: What’s fascinating about those three points you’ve raised there, Andy, is they sort of reinforce all of the experiences we’ve just been discussing, in that, it’s about people that you not only get along with, but get stuff done. And I don’t think I’ve come across someone in tech transfer or all the biobased economy that it isn’t looking to make a difference. And who doesn’t want to get stuff done. So completely expected, in addition to the fact that I think everyone that’s in biobased is trying to make the make a difference. And all of us believe the things we’re doing are making a difference. Some of us get the chance to take big shots on goal; some of us just get to move the ball down the field. But in principle, it’s the whole team that’s getting the ball down the field and getting it into the end zone. It turns out though, that with biobased, there’s lots of end zones and there’s lots of games being played. So…

AS: There are, there are lots of problems to be solved and lots of opportunities to go do it better than what’s being done today. And that’s the whole game. And none of it is an individual sport. It’s all a team sport. So, you’re exactly right.

CB: So what I particularly liked about, you know, why you went to Gevo out of what you were saying there, though, was about those value pools and identifying customers and that segmentation, and actually finding those that do value the proposition, not necessarily just hoping someone values it, but digging through, you know, customers, markets, segments, and actually identifying potential points of partnership and intersection of interest. Because they’re it’s easy to sort of wring your hands and say, ‘I just don’t understand why people aren’t buying this stuff, because it’s just so good’.

AS: It’s interesting that when I first got called and they asked me to join Gevo and they asked me to come help open up sustainable aviation fuels for aviation. And I got thinking about it and I was like, we’re trying to sell sustainable aviation fuel to airlines who can’t afford to invest in a more expensive solution because they’re barely making profits today, most of them. And we’re asking them to change what they’re doing to a more expensive product. We’re asking them to commit to buy that product, which they buy on the spot basis today. And we want them to sign ten-year offtake agreements so we can finance the capital to build a new plant that needs a ten-year capital financing cycle. Right? And it’s like, ‘Why is it this bottle is not going fast?’ That’s makes no sense. Right. And I, I was thinking about it. It’s like, ‘That’s the problem I have to go solve’. Okay. So, we got to figure out how to think differently about what’s what this is all about and how we’re really doing it and, and what that looks like. And so, you’ll see, we are beginning to think much more about, you know, how decarbonisation gets done and who needs to be in that ecosystem. And how do we do that. And SAF is a piece of that. But there’s also corporates and there’s also governments and there’s a whole bunch of people in the ecosystem that will make it happen. And getting those folks aligned to say, this is the better solution is part of the challenge that that makes it interesting. So, it’s really thinking differently about the value proposition and finding those, that segments, that that’ll value this.

CB: I think it’s fair to say that in the absence of regulators and policy, it’s going to be difficult on cost.

AS: The cost to make SAF is not that different than the cost to make typical kerosene. The operating cost to make the molecule is not that terribly different. The difference is kerosene is typically being made in assets that are depreciated. And the only capital they have to pay for is maintenance capital.

CB: So, you think it’s the cost of capital that’s the killer at the moment.

AS: It’s a cost of capital challenge that needs to be done. The other part that I think is really interesting, if you think about the feedstocks piece, is that we’re looking to, to have, if it’s not a waste biomass feedstock, but even if it is a waste mine, somebody’s got to collect it. Somebody’s got to be the farmer of that waste biomass. And if it’s a biomass that’s grown, we want the farmers to put the carbon back in the soil because we can make the soil healthier. We can make the yields more productive. Coming back to your ag points from before, we can make the soil more productive, we can make the yields better. We can do a lot of things that help the agricultural economy produce food and fuel. So, at Gevo, we’ll produce three times as much feed as we will fuel. And it’s healthier feed for the animals than what we’re feeding them as synthetic proteins. So, it’s not a food versus fuel debate…

CB: No, it has to be ‘and’…

AS: It’s a fuel and food contribution. And we ought to be trying to see that the farmer benefits from this by getting for sequestering carbon back where it came from to begin with, in the soil. And so, the climate smart ag stuff and some of the things that that need to be done to help this really become a circular economy are really pretty interesting to be working on.

CB: Yeah, I completely agree. And now has to be, and I think we learned from, the corn maze spike of 2009-10, you know, when you hit the front page of The Economist, it’s either really good or really bad. There’s only two possible outcomes there. And without the industry was on the front page of The Economist, and I think it’s fair to say that was not a good outcome for the industry. It was probably a necessary course correction, by the way. I don’t think people would look back on that course correction as a wrong thing to do. But it was a very dramatic course correction. And yeah, it was interesting talking again, I mentioned Paul Bryan earlier. It was interesting chatting to him about that too, to be honest. He took some views, both from his time at Chevron and at the US Department of Energy. So, he sort of saw two sides of the picture, which were interesting to explore. Andy, it has been terrific talking with you and some of the things you’ve shared with us, the calendars versus stopwatches is a fantastic insight. Andy thanks so much for your time today. Look forward to talking again soon.

AS: Always great to talk with you, Cameron.

spotify-podcast-badge-blk-grn-165x40 Created with Sketch.